Yubo International Biotech Limited Stock
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.935 USD | +4.47% | +16.88% | +211.67% |
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | 18 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
1 day | +4.47% | ||
1 week | +16.88% | ||
Current month | +168.14% | ||
1 month | +345.24% | ||
3 months | +80.50% | ||
6 months | +81.45% | ||
Current year | +211.67% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.935 | +4.47% | 4,190 |
24-05-23 | 0.895 | -3.76% | 61,088 |
24-05-22 | 0.93 | +9.42% | 293,565 |
24-05-21 | 0.8499 | +10.38% | 6,760 |
24-05-20 | 0.77 | -3.75% | 8,010 |
Delayed Quote OTC Markets, May 24, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+211.67% | 112M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.32% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- YBGJ Stock